Tema Obesity & Cardiometabolic ETF (HRTS) Chart & Stock Price History $27.69 +0.28 (+1.02%) As of 04/17/2025 03:30 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHoldingsRatingsBuy This Stock Tema Obesity & Cardiometabolic ETF Stock Price Performance 5 Day Performance+0.18%1 Month Performance-8.10%3 Month Performance-3.52%6 Month Performance-19.53%Year-To-Date Performance-4.09%1 Year Performance-10.10% Receive HRTS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address HRTS Stock Chart for Sunday, April, 20, 2025 HRTS Chart by TradingView Tema Obesity & Cardiometabolic ETF Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2025$27.69$27.69$27.69$27.394,703 shs$53.72 million04/17/2025$27.41$27.69+1.02%$27.69$27.394,703 shs$53.72 million04/16/2025$27.64$27.41-0.83%$27.81$27.233,822 shs$53.18 million04/15/2025$27.92$27.64-1.00%$28.02$27.596,831 shs$53.62 million04/14/2025$27.36$27.92+2.05%$27.95$27.583,839 shs$54.17 million04/11/2025$26.76$27.36+2.24%$27.36$26.651,885 shs$53.08 million04/10/2025$27.41$26.76-2.37%$27.06$26.015,016 shs$51.91 million04/09/2025$26.25$27.41+4.42%$27.43$25.327,801 shs$56.19 million04/09/2025$26.25$27.41+4.42%$27.43$25.327,801 shs$56.19 million04/08/2025$26.56$26.25-1.17%$27.31$26.256,336 shs$53.81 million Get the Latest News and Ratings for HRTS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025$26.56$26.25-1.17%$27.31$26.256,336 shs$53.81 million04/07/2025$26.81$26.56-0.93%$26.90$25.6225,910 shs$54.45 million04/04/2025$28.61$26.81-6.29%$28.00$26.8144,958 shs$54.96 million04/03/2025$29.01$28.61-1.38%$28.88$28.516,985 shs$58.65 million04/02/2025$28.60$29.01+1.43%$29.01$28.6125,004 shs$59.47 million04/01/2025$29.33$28.60-2.49%$29.12$28.5122,131 shs$58.63 million03/31/2025$29.47$29.33-0.48%$29.38$28.8821,233 shs$60.13 million03/28/2025$29.46$29.47+0.03%$29.53$29.402,279 shs$60.41 million03/27/2025$29.51$29.46-0.17%$29.65$29.465,555 shs$60.39 million03/26/2025$29.95$29.51-1.47%$29.73$29.512,473 shs$60.50 million03/25/2025$30.29$29.95-1.12%$30.47$29.812,241 shs$61.40 million03/24/2025$29.98$30.29+1.03%$30.35$29.997,933 shs$62.09 million03/21/2025$30.13$29.98-0.50%$30.05$29.812,524 shs$62.96 million03/20/2025$30.05$30.13+0.27%$30.19$29.9011,205 shs$63.27 million03/19/2025$29.99$30.05+0.20%$30.09$29.824,155 shs$63.11 million Related Companies Themes Lithium & Battery Metal Miners ETF Stock Price Chart Themes Copper Miners ETF Stock Price Chart Stone Ridge 2060 Inflation Protected Longevity Income ETF Stock Price Chart X-Square Balanced Fund, LLC A Stock Price Chart Stone Ridge 2059 Inflation-Protected Longevity Income ETF Stock Price Chart Ocean Park International ETF Stock Price Chart Themes Robotics & Automation ETF Stock Price Chart Themes Uranium & Nuclear ETF Stock Price Chart ARK 21Shares Active Ethereum Futures Strategy ETF Stock Price Chart Stone Ridge 2061 Inflation Protected Longevity Income ETF Stock Price Chart Receive HRTS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:HRTS) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Obesity & Cardiometabolic ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Obesity & Cardiometabolic ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
